← Leaderboards
Alan Pestronk
Washington University
$192,545
Attributed
$192,545
Total exposure
22
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $70.3K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$192,545 · 22
By mechanism
M01$192,545 · 22
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Chyi S Hsieh$20,068,670
- Samuel Klein$33,055,933
- Sheng-Kwei Song$14,973,079
- Josiah Gerdts$603,607
- Chelsea Renee Parker Harp$77,937
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationClinical ResearchDrug Screening /EvaluationAmyotrophic Lateral SclerosisNervous System Disorder ChemotherapyNeuromuscular Disorder ChemotherapyMuscle StrengthClinical TrialsResourcesPlacebosResearch PersonnelInstitutionFundingMaleComputer Retrieval Of Information On Scientific Projects DatabaseGrantSourceUnited States National Institutes Of HealthNeuroprotectantsMuscle Disorder ChemotherapyMuscular DystrophyChild (0-11)Adolescence (12-20)
Grant awards (40)
COMBINATION TRIAL IN ALS$3,932
M01 · FY2007 · RR · contact PI
TRANSLATIONAL RESEARCH IN THE DYSTROPHINOPATHIES$2,575
M01 · FY2007 · RR · contact PI
MINOCYCLINE STUDY IN ALS PATIENTS$1,084
M01 · FY2007 · RR · contact PI
CLINICAL TRIAL OF CEFTRIAXONE IN SUBJECTS WITH ALS$949
M01 · FY2007 · RR · contact PI
PENTOXIFYLLINE AS A RESCUE TREATMENT IN DUCHENNE MUSCULAR DYSTROPHY$542
M01 · FY2007 · RR · contact PI
HIGH DOSE COQ10 IN ALS$406
M01 · FY2007 · RR · contact PI
STEROID THERAPY IN DUCHENNE MUSCULAR DYSTROPHY (DMD)$271
M01 · FY2007 · RR · contact PI
MINOCYCLINE STUDY IN ALS PATIENTS$23,740
M01 · FY2006 · RR · contact PI
TRANSLATIONAL RESEARCH IN THE DYSTROPHINOPATHIES$12,078
M01 · FY2006 · RR · contact PI
PENTOXIFYLLINE AS A RESCUE TREATMENT IN DUCHENNE MUSCULAR DYSTROPHY$4,582
M01 · FY2006 · RR · contact PI
STEROID THERAPY IN DUCHENNE MUSCULAR DYSTROPHY (DMD)$2,499
M01 · FY2006 · RR · contact PI
PILOT TRIAL OF PENTOXIFYLLINE IN DUCHENNE MUSCULAR DYSTROPHY (DMD)$2,499
M01 · FY2006 · RR · contact PI
HIGH DOSE COQ10 IN ALS$1,666
M01 · FY2006 · RR · contact PI
MINOCYCLINE STUDY IN ALS PATIENTS$41,488
M01 · FY2005 · RR
TRANSLATIONAL RESEARCH IN THE DYSTROPHINOPATHIES$11,913
M01 · FY2005 · RR
CLINICAL TRIAL OF CELEBREX IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS$6,984
M01 · FY2005 · RR
USE OF COQ10 IN ALS PATIENTS$5,751
M01 · FY2005 · RR
PILOT TRIAL OF PENTOXIFYLLINE IN DUCHENNE MUSCULAR DYSTROPHY (DMD)$3,287
M01 · FY2005 · RR
TRANSLATIONAL RESEARCH IN THE DYSTROPHINOPATHIES$829
M01 · FY2005 · RR
Clinical Trial of Celebrex in Subjects with Amyotrophic Lateral Sclerosis.$36,408
M01 · FY2004 · RR
Use of CoQ10 in ALS Patients$21,397
M01 · FY2004 · RR
Minocycline Study in ALS Patients$7,665
M01 · FY2004 · RR
Efficacy and safety of oxandrolone for boys with Duchenne's muscular dystrophy$0
M01 · FY2002 · RR
SR 57746A IN PATIENTS WITH ALS RECEIVING RILUZOLE$0
M01 · FY2002 · RR
RECOMBINANT HUMAN NERVE GROWTH FACTOR IN PATIENTS WITH DIABETIC NEUROPATHY$0
M01 · FY2002 · RR
RANDOMIZED CLINICAL TRIAL OF OXANDRIN ON STRENGTH IN BOYS WITH DMD$0
M01 · FY2002 · RR
STUDY OF SR 57764A IN PATIENTS WITH ALS$0
M01 · FY2002 · RR
RITUXAN IN POLYNEUROPATHIES ASSOCIATED WITH SERUM IGM AUTOANTIBODIES$0
M01 · FY2002 · RR
STUDY OF SR 57764A IN PATIENTS WITH ALS$0
M01 · FY2001 · RR
Efficacy and safety of oxandrolone for boys with Duchenne's muscular dystrophy$0
M01 · FY2001 · RR
RITUXAN IN POLYNEUROPATHIES ASSOCIATED WITH SERUM IGM AUTOANTIBODIES$0
M01 · FY2001 · RR
RECOMBINANT HUMAN NERVE GROWTH FACTOR IN PATIENTS WITH DIABETIC NEUROPATHY$0
M01 · FY2001 · RR
RANDOMIZED CLINICAL TRIAL OF OXANDRIN ON STRENGTH IN BOYS WITH DMD$0
M01 · FY2001 · RR
SR 57746A IN PATIENTS WITH ALS RECEIVING RILUZOLE$0
M01 · FY2001 · RR
STUDY OF SR 57764A IN PATIENTS WITH ALS$0
M01 · FY2000 · RR
Efficacy and safety of oxandrolone for boys with Duchenne's muscular dystrophy$0
M01 · FY2000 · RR
RITUXAN IN POLYNEUROPATHIES ASSOCIATED WITH SERUM IGM AUTOANTIBODIES$0
M01 · FY2000 · RR
RECOMBINANT HUMAN NERVE GROWTH FACTOR IN PATIENTS WITH DIABETIC NEUROPATHY$0
M01 · FY2000 · RR
RANDOMIZED CLINICAL TRIAL OF OXANDRIN ON STRENGTH IN BOYS WITH DMD$0
M01 · FY2000 · RR
SR 57746A IN PATIENTS WITH ALS RECEIVING RILUZOLE$0
M01 · FY2000 · RR